Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07299357

Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial

Sponsor: Istituto Clinico Humanitas

View on ClinicalTrials.gov

Summary

The study objective is to evaluate the use of Stereotactic Body Radiotherapy (high dose of radiation in a few fractions) to cure primary renal cancer in those patients that are not indicated to surgery (high risk of complications, refusal of the patient). This therapy is already used in clinical setting for many tumors with good tolerance as it is not invasive, does not require anesthesia and hospitalization making it suitable for elderly people and frail patients. However there are not enough information regarding the use of ablative doses for the cure of renal cancer and for this reason this study aims to support the use of Stereotactic Body Radiotherapy as a standard of care for inoperable primary renal tumor. This is an observational study, so it collects data from clinical pratice only and does not request study specific procedures.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

53

Start Date

2026-01

Completion Date

2033-12

Last Updated

2026-01-21

Healthy Volunteers

No

Conditions

Interventions

RADIATION

Stereotactic body radiotherapy (SBRT)

high dose radiation in few fractions

Locations (2)

Humanitas PIO X

Milan, Milan, Italy

Irccs Humanitas Research Hospital

Rozzano, Milan, Italy